COMP <GO>
OBIO vs USNA // RETURN ON INVESTED CAPITAL (ROIC)
Orchestra BioMed Holdings Inc. (NASDAQ) VS. USANA Health Sciences Inc. (NYSE) • 15-METRIC TALLY: OBIO 4
— USNA 6
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: USNA
LAST: $5.91 (-2.96%) • MKT CAP: $355.2M
roic
-35.00%
LAST: $14.31 (-0.21%) • MKT CAP: $264.4M
roic
7.90%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (OBIO VS. USNA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | OBIO | USNA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 96.00% | 78.30% | +17.70 | OBIO | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | -35.00% | 7.90% | -42.90 | USNA | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 2.7x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -13.51% | 3.22% | -16.73 | USNA | /fcf-yield <GO> |
| Operating Margin | -60.00% | 4.00% | -64.00 | USNA | /operating-margins <GO> |
| Net Profit Margin | -60.00% | 1.20% | -61.20 | USNA | /net-margins <GO> |
| Revenue Growth (YoY) | 180.00% | 8.30% | +171.70 | OBIO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | 3.56 | -3.36 | USNA | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 7/9 | -2.00 | USNA | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 52.8 | 45.3 | +7.50 | OBIO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 22.9x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $355.2M | $264.4M | $90.8M | OBIO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | OBIO REV | USNA REV | OBIO GROSS % | USNA GROSS % | OBIO FCF | USNA FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $33.5M | $925.3M | 98.0% | 78.3% | -$49.5M | $8.5M |
| FY 2024 | $2.6M | $854.5M | 92.3% | 81.1% | -$50.8M | $50.9M |
| FY 2023 | $2.8M | $921.0M | — | — | -$46.1M | $70.6M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
OBIO // BETA —
USNA // BETA —